First Time Loading...

Entera Bio Ltd
NASDAQ:ENTX

Watchlist Manager
Entera Bio Ltd Logo
Entera Bio Ltd
NASDAQ:ENTX
Watchlist
Price: 2 USD -4.31% Market Closed
Updated: Jun 8, 2024

Entera Bio Ltd
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Entera Bio Ltd
Free Cash Flow Peer Comparison

Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Entera Bio Ltd
NASDAQ:ENTX
Free Cash Flow
-$7.3m
CAGR 3-Years
12%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Free Cash Flow
-$3.7m
CAGR 3-Years
9%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Free Cash Flow
-$1.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
18%
B
BioLine RX Ltd
TASE:BLRX
Free Cash Flow
-$22.9m
CAGR 3-Years
0%
CAGR 5-Years
8%
CAGR 10-Years
-2%
Urogen Pharma Ltd
NASDAQ:URGN
Free Cash Flow
-$82.5m
CAGR 3-Years
6%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Free Cash Flow
-₪27.2m
CAGR 3-Years
-19%
CAGR 5-Years
-15%
CAGR 10-Years
-12%

See Also

What is Entera Bio Ltd's Free Cash Flow?
Free Cash Flow
-7.3m USD

Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Free Cash Flow amounts to -7.3m USD.

What is Entera Bio Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
6%

Over the last year, the Free Cash Flow growth was 42%. The average annual Free Cash Flow growth rates for Entera Bio Ltd have been 12% over the past three years , 6% over the past five years .